Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Möller, Hans-Jürgen
2007.
Evaluación clínica de los síntomas negativos de la esquizofrenia.
European psychiatry (Ed. Española),
Vol. 14,
Issue. 8,
p.
375.
Möller, Hans-Jürgen
Riedel, Michael
Jäger, Markus
Wickelmaier, Florian
Maier, Wolfgang
Kühn, Kai-Uwe
Buchkremer, Gerhard
Heuser, Isabella
Klosterkötter, Joachim
Gastpar, Markus
Braus, Dieter F.
Schlösser, Ralf
Schneider, Frank
Ohmann, Christian
Riesbeck, Mathias
and
Gaebel, Wolfgang
2008.
Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia.
The International Journal of Neuropsychopharmacology,
Vol. 11,
Issue. 07,
Möller, Hans-Jürgen
2008.
Systematic of psychiatric disorders between categorical and dimensional approaches.
European Archives of Psychiatry and Clinical Neuroscience,
Vol. 258,
Issue. S2,
p.
48.
Möller, Hans-Jürgen
2008.
Drug Treatment of Depressive Symptoms in Schizophrenia.
Clinical Schizophrenia & Related Psychoses,
Vol. 1,
Issue. 4,
p.
328.
Lysaker, Paul H.
Vohs, Jenifer L.
and
Tsai, Jack
2009.
Negative symptoms and concordant impairments in attention in schizophrenia: Associations with social functioning, hope, self-esteem and internalized stigma.
Schizophrenia Research,
Vol. 110,
Issue. 1-3,
p.
165.
Lecardeur, Laurent
Briand, Catherine
Prouteau, Antoinette
Lalonde, Pierre
Nicole, Luc
Lesage, Alain
and
Stip, Emmanuel
2009.
Preserved awareness of their cognitive deficits in patients with schizophrenia: Convergent validity of the SSTICS.
Schizophrenia Research,
Vol. 107,
Issue. 2-3,
p.
303.
Cotton, S.M.
Gleeson, J.F.M.
Alvarez-Jimenez, M.
and
McGorry, P.D.
2010.
Quality of life in patients who have remitted from their first episode of psychosis.
Schizophrenia Research,
Vol. 121,
Issue. 1-3,
p.
259.
Miettunen, J.
and
Jaaskelainen, E.
2010.
Sex Differences in Wisconsin Schizotypy Scales--A Meta-analysis.
Schizophrenia Bulletin,
Vol. 36,
Issue. 2,
p.
347.
Tsai, Jack
Lysaker, Paul H.
and
Vohs, Jenifer L.
2010.
Negative symptoms and concomitant attention deficits in schizophrenia: Associations with prospective assessments of anxiety, social dysfunction, and avoidant coping.
Journal of Mental Health,
Vol. 19,
Issue. 2,
p.
184.
Meyer, Urs
2011.
Anti-inflammatory signaling in schizophrenia.
Brain, Behavior, and Immunity,
Vol. 25,
Issue. 8,
p.
1507.
Mairs, Hilary
Lovell, Karina
Campbell, Malcolm
and
Keeley, Philip
2011.
Development and Pilot Investigation of Behavioral Activation for Negative Symptoms.
Behavior Modification,
Vol. 35,
Issue. 5,
p.
486.
Altamura, A. Carlo
Serati, Marta
Albano, Alessandra
Paoli, Riccardo A.
Glick, Ira D.
and
Dell’Osso, Bernardo
2011.
An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses.
European Archives of Psychiatry and Clinical Neuroscience,
Vol. 261,
Issue. 7,
p.
489.
Marston, Hugh M
Martin, Frederic DC
Papp, Mariusz
Gold, Lisa
Wong, Erik HF
and
Shahid, Mohammed
2011.
Attenuation of chronic mild stress-induced ‘anhedonia’ by asenapine is not associated with a ‘hedonic’ profile in intracranial self-stimulation.
Journal of Psychopharmacology,
Vol. 25,
Issue. 10,
p.
1388.
Meyer, Urs
Schwarz, Markus J.
and
Müller, Norbert
2011.
Inflammatory processes in schizophrenia: A promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond.
Pharmacology & Therapeutics,
Vol. 132,
Issue. 1,
p.
96.
Hovington, Cindy L
Bodnar, Michael
Joober, Ridha
Malla, Ashok K
and
Lepage, Martin
2012.
Identifying persistent negative symptoms in first episode psychosis.
BMC Psychiatry,
Vol. 12,
Issue. 1,
Barkhof, E.
Meijer, C.J.
de Sonneville, L.M.J.
Linszen, D.H.
and
de Haan, L.
2012.
Interventions to improve adherence to antipsychotic medication in patients with schizophrenia–A review of the past decade.
European Psychiatry,
Vol. 27,
Issue. 1,
p.
9.
Lysaker, Paul H.
Erikson, Molly
Macapagal, Kathryn R.
Tunze, Chloe
Gilmore, Emily
and
Ringer, Jamie M.
2012.
Development of Personal Narratives as a Mediator of the Impact of Deficits in Social Cognition and Social Withdrawal on Negative Symptoms in Schizophrenia.
Journal of Nervous & Mental Disease,
Vol. 200,
Issue. 4,
p.
290.
López, Abraham
Mendieta, Laura
Prades, Roger
Royo, Soledad
Tarragó, Teresa
and
Giralt, Ernest
2013.
Peptide Pop Inhibitors for the Treatment of the Cognitive Symptoms of Schizophrenia.
Future Medicinal Chemistry,
Vol. 5,
Issue. 13,
p.
1509.
Hinkelmann, Kim
Yassouridis, Alexander
Kellner, Michael
Jahn, Holger
Wiedemann, Klaus
and
Raedler, Thomas J.
2013.
No Effects of Antidepressants on Negative Symptoms in Schizophrenia.
Journal of Clinical Psychopharmacology,
Vol. 33,
Issue. 5,
p.
686.
Lutgens, Danyael
Lepage, Martin
Manchanda, Rahul
and
Malla, Ashok
2013.
Persistent negative symptoms in schizophrenia: survey of Canadian psychiatrists.
International Psychiatry,
Vol. 10,
Issue. 3,
p.
69.
Comments
No Comments have been published for this article.